Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
96 participants
INTERVENTIONAL
2017-01-01
2020-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
NCT03636451
Paracervical Block for Pain Control With Osmotic Dilator Placement
NCT02354092
Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion
NCT03508804
Paracervical Versus Intracervical Lidocaine
NCT00816751
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
NCT00855842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
12 mL arm
Intervention:
* Syringe loaded with 12 mL of 1% lidocaine (120 mg); 22-gauge spinal needle
* 2 mL injected at the tenaculum site, either 6 or 12 o'clock superficially into the cervix
* The tenaculum is immediately placed at the previously injected site
* The remaining 10 mL are slowly injected into the cervicovaginal junction in two equal aliquots at 4 and 8 o'clock; the injection is continuous from superficial to deep (3 cm) to superficial (injecting with insertion and withdrawal)
* No wait time between injection and dilator insertion
12 mL paracervical block
Injection of 12 mL of lidocaine
20 mL arm
Intervention:
* Syringe loaded with 20 mL of 1% lidocaine (120 mg); 22-gauge spinal needle
* 2 mL injected at the tenaculum site, either 6 or 12 o'clock superficially into the cervix
* The tenaculum is immediately placed at the previously injected site
* The remaining 18 mL are slowly injected into the cervicovaginal junction in two equal aliquots at 4 and 8 o'clock; the injection is continuous from superficial to deep (3 cm) to superficial (injecting with insertion and withdrawal)
* No wait time between injection and dilator insertion
20 mL paracervical block
Injection of 20 mL of lidocaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
12 mL paracervical block
Injection of 12 mL of lidocaine
20 mL paracervical block
Injection of 20 mL of lidocaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intrauterine pregnancy ≥16 weeks gestation
* English speaking competency
* Willing and able to sign consent forms
* Agree to comply with study procedures
Exclusion Criteria
* IV conscious sedation
* Known allergy to study medication (lidocaine)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shaw KA, Lerma K, Hughes T, Hastings C, Fok WK, Blumenthal PD. A Comparison of Paracervical Block Volumes Before Osmotic Dilator Placement: A Randomized Controlled Trial. Obstet Gynecol. 2021 Sep 1;138(3):443-448. doi: 10.1097/AOG.0000000000004485.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-43789
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.